The Effects of L-Dopa and N-(Alpha-Linolenoyl) Tyrosine on 6-Oh-Da Lesions on Dopamine Level and Activity, Dyskinesia and Homocysteinemia in Rats

S Yehuda; S Rabinovitz-Shenkar

doi:10.4236/apd.2013.21001

The Effects of L-Dopa and N-(Alpha-Linolenoyl) Tyrosine on 6-Oh-Da Lesions on Dopamine Level and Activity, Dyskinesia and Homocysteinemia in Rats

S Yehuda
, S Rabinovitz-Shenkar

Research output: Contribution to journal › Article › peer-review

Abstract

The three major issues in L-DOPA therapy for Parkinson are: 1) rapid tolerance; 2) induced dyskinesia; 3) hyperhomocysteinemia. The newly synthesized molecule, which is an amide bond molecule composed of L-tyrosine and alphalinolenic acid, ie, N-(alpha-linolenoyl) …

Original language	English
Pages (from-to)	1-4
Number of pages	4
Journal	Advances in Parkinson's Disease
Volume	2
Issue number	1
DOIs	https://doi.org/10.4236/apd.2013.21001
State	Published - 2013

Bibliographical note

Query date: 2021-12-30 10:33:04

Access to Document

10.4236/apd.2013.21001

https://www.scirp.org/html/1-2620005_27824.htm

Cite this

@article{83116da8eff64f849a804e550be9079a,

title = "The Effects of L-Dopa and N-(Alpha-Linolenoyl) Tyrosine on 6-Oh-Da Lesions on Dopamine Level and Activity, Dyskinesia and Homocysteinemia in Rats",

abstract = "The three major issues in L-DOPA therapy for Parkinson are: 1) rapid tolerance; 2) induced dyskinesia; 3) hyperhomocysteinemia. The newly synthesized molecule, which is an amide bond molecule composed of L-tyrosine and alphalinolenic acid, ie, N-(alpha-linolenoyl) …",

author = "S Yehuda and S Rabinovitz-Shenkar",

note = "Query date: 2021-12-30 10:33:04",

year = "2013",

doi = "10.4236/apd.2013.21001",

language = "אנגלית",

volume = "2",

pages = "1--4",

journal = "Advances in Parkinson's Disease",

issn = "2169-9720",

publisher = "Scientific Research Publishing",

number = "1",

}

TY - JOUR

T1 - The Effects of L-Dopa and N-(Alpha-Linolenoyl) Tyrosine on 6-Oh-Da Lesions on Dopamine Level and Activity, Dyskinesia and Homocysteinemia in Rats

AU - Yehuda, S

AU - Rabinovitz-Shenkar, S

N1 - Query date: 2021-12-30 10:33:04

PY - 2013

Y1 - 2013

N2 - The three major issues in L-DOPA therapy for Parkinson are: 1) rapid tolerance; 2) induced dyskinesia; 3) hyperhomocysteinemia. The newly synthesized molecule, which is an amide bond molecule composed of L-tyrosine and alphalinolenic acid, ie, N-(alpha-linolenoyl) …

AB - The three major issues in L-DOPA therapy for Parkinson are: 1) rapid tolerance; 2) induced dyskinesia; 3) hyperhomocysteinemia. The newly synthesized molecule, which is an amide bond molecule composed of L-tyrosine and alphalinolenic acid, ie, N-(alpha-linolenoyl) …

UR - https://www.mendeley.com/catalogue/cbb9191e-4f64-3f35-8c45-e3c94cc41971/

U2 - 10.4236/apd.2013.21001

DO - 10.4236/apd.2013.21001

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

SN - 2169-9720

VL - 2

SP - 1

EP - 4

JO - Advances in Parkinson's Disease

JF - Advances in Parkinson's Disease

IS - 1

ER -

The Effects of L-Dopa and N-(Alpha-Linolenoyl) Tyrosine on 6-Oh-Da Lesions on Dopamine Level and Activity, Dyskinesia and Homocysteinemia in Rats

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this